ZBH vs. JNJ

Last updated Apr 1, 2026

Compare and contrast key facts about Zimmer Biomet Holdings, Inc. (ZBH) and Johnson & Johnson (JNJ).

Performance

ZBH vs. JNJ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Zimmer Biomet Holdings, Inc. (ZBH) and Johnson & Johnson (JNJ). The values are adjusted to include any dividend payments, if applicable.

ZBH vs. JNJ - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ZBH Zimmer Biomet Holdings, Inc.	0.83%	-14.03%	-12.46%	-3.81%	4.24%	-17.02%	3.77%	45.37%	-13.30%	17.86%
JNJ Johnson & Johnson	18.74%	47.48%	-4.81%	-8.58%	5.97%	11.44%	10.82%	16.22%	-5.13%	24.43%

Fundamentals

EPS ZBH : $4.27 JNJ : $11.04
PE Ratio ZBH : 21.16 JNJ : 22.15
PEG Ratio ZBH : 0.37 JNJ : 0.74
PS Ratio ZBH : 5.33 JNJ : 6.30
Total Revenue (TTM) ZBH : $2.24B JNJ : $94.19B
Gross Profit (TTM) ZBH : $1.27B JNJ : $68.56B
EBITDA (TTM) ZBH : $1.76B JNJ : $39.85B

Returns By Period

In the year-to-date period, ZBH achieves a 0.83% return, which is significantly lower than JNJ's 18.74% return. Over the past 10 years, ZBH has underperformed JNJ with an annualized return of -0.60%, while JNJ has yielded a comparatively higher 11.41% annualized return.

ZBH

• 1D: 2.31%
• 1M: -7.90%
• YTD: 0.83%
• 6M: -7.71%
• 1Y: -19.27%
• 3Y*: -10.42%
• 5Y*: -9.50%
• 10Y*: -0.60%

JNJ

• 1D: 0.80%
• 1M: -1.61%
• YTD: 18.74%
• 6M: 33.37%
• 1Y: 51.50%
• 3Y*: 19.92%
• 5Y*: 11.57%
• 10Y*: 11.41%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

ZBH vs. JNJ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ZBH

ZBH Risk / Return Rank: 16
ZBH Sharpe Ratio Rank: 15
ZBH Sortino Ratio Rank: 17
ZBH Omega Ratio Rank: 15
ZBH Calmar Ratio Rank: 14
ZBH Martin Ratio Rank: 20

JNJ

JNJ Risk / Return Rank: 94
JNJ Sharpe Ratio Rank: 96
JNJ Sortino Ratio Rank: 95
JNJ Omega Ratio Rank: 96
JNJ Calmar Ratio Rank: 93
JNJ Martin Ratio Rank: 93

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ZBH vs. JNJ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Zimmer Biomet Holdings, Inc. (ZBH) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ZBH	JNJ	Difference
Sharpe ratio Return per unit of total volatility	-0.62	2.71	-3.33
Sortino ratio Return per unit of downside risk	-0.66	3.40	-4.06
Omega ratio Gain probability vs. loss probability	0.90	1.52	-0.62
Calmar ratio Return relative to maximum drawdown	-0.78	4.55	-5.33
Martin ratio Return relative to average drawdown	-1.16	13.23	-14.39
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ZBH vs. JNJ - Sharpe Ratio Comparison

The current ZBH Sharpe Ratio is -0.62, which is lower than the JNJ Sharpe Ratio of 2.71. The chart below compares the historical Sharpe Ratios of ZBH and JNJ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	ZBH	JNJ	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.62	2.71	-3.33
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.37	0.70	-1.06
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.02	0.62	-0.65
Sharpe Ratio (All Time) Calculated using the full available price history	0.19	0.54	-0.35

Correlation

The correlation between ZBH and JNJ is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

ZBH vs. JNJ - Dividend Comparison

ZBH's dividend yield for the trailing twelve months is around 1.06%, less than JNJ's 2.13% yield.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ZBH Zimmer Biomet Holdings, Inc.	1.06%	1.07%	0.91%	0.79%	0.75%	0.76%	0.62%	0.64%	0.93%	0.80%	0.93%	0.86%
JNJ Johnson & Johnson	2.13%	2.48%	3.40%	3.00%	2.52%	2.45%	2.53%	2.57%	2.74%	2.38%	2.73%	2.87%

Drawdowns

ZBH vs. JNJ - Drawdown Comparison

The maximum ZBH drawdown since its inception was -65.03%, which is greater than JNJ's maximum drawdown of -50.67%. Use the drawdown chart below to compare losses from any high point for ZBH and JNJ.

Drawdown Indicators

	ZBH	JNJ	Difference
Max Drawdown Largest peak-to-trough decline	-65.03%	-50.67%	-14.36%
Max Drawdown (1Y) Largest decline over 1 year	-23.33%	-8.42%	-14.91%
Max Drawdown (5Y) Largest decline over 5 years	-48.59%	-18.41%	-30.18%
Max Drawdown (10Y) Largest decline over 10 years	-49.73%	-27.37%	-22.36%
Current Drawdown Current decline from peak	-45.62%	-1.66%	-43.96%
Average Drawdown Average peak-to-trough decline	-19.86%	-11.90%	-7.96%
Ulcer Index Depth and duration of drawdowns from previous peaks	15.94%	4.04%	+11.90%

Volatility

ZBH vs. JNJ - Volatility Comparison

Zimmer Biomet Holdings, Inc. (ZBH) has a higher volatility of 7.59% compared to Johnson & Johnson (JNJ) at 4.48%. This indicates that ZBH's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ZBH	JNJ	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.59%	4.48%	+3.11%
Volatility (6M) Calculated over the trailing 6-month period	23.32%	11.09%	+12.23%
Volatility (1Y) Calculated over the trailing 1-year period	31.06%	19.14%	+11.92%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	26.04%	16.68%	+9.36%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	28.11%	18.33%	+9.78%

Financials

ZBH vs. JNJ - Profitability Comparison

The chart below illustrates the profitability comparison between Zimmer Biomet Holdings, Inc. and Johnson & Johnson over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

ZBH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Zimmer Biomet Holdings, Inc. reported a gross profit of -3.01B and revenue of -3.74B. Therefore, the gross margin over that period was 80.5%.

JNJ - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Johnson & Johnson reported a gross profit of 21.22B and revenue of 24.56B. Therefore, the gross margin over that period was 86.4%.

ZBH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Zimmer Biomet Holdings, Inc. reported an operating income of 0.00 and revenue of -3.74B, resulting in an operating margin of 0.0%.

JNJ - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Johnson & Johnson reported an operating income of 5.39B and revenue of 24.56B, resulting in an operating margin of 22.0%.

ZBH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Zimmer Biomet Holdings, Inc. reported a net income of 0.00 and revenue of -3.74B, resulting in a net margin of 0.0%.

JNJ - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Johnson & Johnson reported a net income of 5.12B and revenue of 24.56B, resulting in a net margin of 20.8%.